| P2093 | author name string | J Tan | |
| | D Morgan | |
| | T Mori | |
| | J Zeng | |
| | F Fernandez | |
| | H Hou | |
| | Y Bai | |
| | Deyan Luo | |
| | T Town | |
| | B Giunta | |
| | D Obregon | |
| | J Ehrhart | |
| | W V Nikolic | |
| P2860 | cites work | Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage | Q24791704 |
| | CD40-CD40 ligand | Q28143324 |
| | Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization | Q28185520 |
| | T-cell vaccination in multiple sclerosis: update on clinical application and mode of action | Q28271190 |
| | Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy | Q28359737 |
| | The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 |
| | Alzheimer's disease | Q29616743 |
| | Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse | Q29619237 |
| | Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 |
| | Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease | Q33943122 |
| | Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. | Q33947934 |
| | Human genetic defects in class-switch recombination (hyper-IgM syndromes). | Q34360486 |
| | CD40 signaling and Alzheimer's disease pathogenesis. | Q34386101 |
| | The hyper IgM syndrome | Q34561768 |
| | Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety | Q34687112 |
| | CD40-CD40L interaction in Alzheimer's disease. | Q34750476 |
| | Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis | Q34787127 |
| | The role of microglia in Alzheimer's disease: friend or foe? | Q34976952 |
| | A safer vaccine for Alzheimer's disease? | Q35019424 |
| | Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases | Q35022580 |
| | The CD40-CD154 interaction in B cell-T cell liaisons | Q35145640 |
| | Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid | Q35762247 |
| | Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. | Q35843366 |
| | Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage | Q35844472 |
| | Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease | Q35998995 |
| | T-cells in Alzheimer's disease. | Q36295994 |
| | Expression of the activation marker urokinase plasminogen-activator receptor in cultured human central nervous system microglia | Q36827290 |
| | Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease | Q37118356 |
| | Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. | Q40328434 |
| | Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. | Q40341534 |
| | Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease | Q41753192 |
| | Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury | Q43832218 |
| | Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. | Q44824312 |
| | Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses | Q45415101 |
| | Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. | Q46303283 |
| | Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. | Q46715173 |
| | Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases | Q46847222 |
| | A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease | Q47583762 |
| | Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice | Q48196554 |
| | Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice | Q48196624 |
| | Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease | Q48300537 |
| | Abeta40 inhibits amyloid deposition in vivo. | Q48305645 |
| | Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease | Q48349951 |
| | Alzheimer disease's double-edged vaccine | Q48363044 |
| | Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. | Q48363055 |
| | Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice | Q48404833 |
| | Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). | Q48453604 |
| | Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice | Q48459353 |
| | Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. | Q48886200 |
| | Co-expression of multiple transgenes in mouse CNS: a comparison of strategies | Q48889458 |
| | Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. | Q51686248 |
| | Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42. | Q53242663 |
| | Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. | Q53338394 |
| | CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. | Q53369015 |
| | Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G). | Q54481541 |
| | Clinical spectrum of X-linked hyper-IgM syndrome | Q57075392 |
| | Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12 | Q72997029 |
| | Patients with Alzheimer's disease display a pro-inflammatory phenotype | Q73405979 |
| | Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells | Q73827793 |
| | CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway | Q74291010 |
| | Transformation of leech microglial cell morphology and properties following co-culture with injured central nervous system tissue | Q74447173 |
| | Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice | Q78758456 |
| | CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses | Q78762518 |
| | CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation | Q82310803 |
| P433 | issue | 2 | |
| P921 | main subject | cerebral amyloid angiopathy | Q191562 |
| P304 | page(s) | 336-353 | |
| P577 | publication date | 2007-10-16 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation | |
| P478 | volume | 29 | |